The 2025 ASTRO annual meeting featured a prostate cancer session and a presentation by Dr. Angela Jia discussing the clinical ...
Benign prostatic hyperplasia surgical treatment market was valued at US$ 10.5 billion in 2024 and is projected to hit the market valuation of US$ 16.5 billion by 2033 at a CAGR of 5.1% during the ...
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...
According to University Hospitals, Cutler Center for Men members are 37% more likely to have at least one doctor’s visit in the last year with 70% more likely to have a PSA test for prostate cancer.
Cosmos Health is at a turning point in its journey. We have aligned every business unit around a common goal: creating a global healthcare and life sciences platform that integrates pharmaceuticals, ...
The MARCAP Consortium is the largest independent data repository and statistical analysis team, with Dr. Spratt and Dr. Amar Kishan as co-primary investigators. The purpose of the first MARCAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback